期刊文献+

基于PCR原理富集低丰度DNA突变的检测技术 被引量:3

Recent advances in PCR-based methods for the enrichment of minority alleles and mutations
原文传递
导出
摘要 检测生物样本中低丰度的DNA突变或微量等位基因,在癌症、产前诊断及传染病等领域都有很重要的应用价值。近年来发展起来的基于PCR原理富集低丰度DNA突变的常用实验技术,包括低变性温度下的复合PCR(COLD—PCR)、改良型完全富集COLD—PCR(ice—COLD—PCR)、温度耐受性PCR(TF—PCR)、肽核酸钳PCR(PNA—mediated PCR)、野生型阻滞扩增PCR(WTB—PCR)以及数字PCR(digital PCR)等,其基本原理、发展进程以及各自的优缺点各有不同。富集低丰度DNA突变的PCR技术在疾病检测中有一定应用价值。(中华捡验医学杂志,2014,37:958—963) Detection of low-level somatic DNA mutations and minority alleles within a wild-type sample is crucial in fields of medicine, such as cancer, prenatal diagnosis and infectious diseases. Increasing enrichment methods have been developed to study this challenging area. They are typically segregate by their ability to enrich for, and detect, either known or unknown mutations, including COLD- PCR, ice-COLD-PCR, TT-PCR, PNA-mediated PCR, WTB-PCR and digital PCR. In this review, we discuss theoretical principles and relative advantages and disadvantages of these techniques, and put an emphasis on their applications in fields of diseases. (Chin J Lab Med,2014,37:958-963)
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第12期958-963,共6页 Chinese Journal of Laboratory Medicine
基金 国家自然科学基金资助项目(31171615)
关键词 DNA突变分析 聚合酶链反应 等位基因 DNA mutational analysis Polymerase chain reaction Alleles
  • 相关文献

参考文献2

二级参考文献40

  • 1Conrads TP,Fusaro VA,Ross S,et al.High-resolution serum proteomic features for ovarian cancer detection.Endocr Relat Cancer,2004,11:163-178.
  • 2Cubedo J,Padró T,García-Moll X,et al.Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction.J Prote Res,2011,10:211-220.
  • 3Mehan MR,Ayers D,Thirstrup D,et al.Protein signature of lung cancer tissues.PLoS One,2012,7:e35157.
  • 4Brown DL,Andreotti RF,Lee SI,et al.ACR appropriateness criteria.Ovarian cancer screening.Ultrasound Quarterly,2010,26:219-223.
  • 5Lorkova L,Pospisilova J,Lacheta J,et al.Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients:a potential biomarker identified by proteomics.Oncology Reports,2012,27:318-324.
  • 6Clarke CH,Yip C,Badgwell D,et al.Proteomic biomarkers apolipoprotein Al,truncated transthyretin,and connective tissue activating protein Ⅲ enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.Gynecologic Oncology,2011,122:548-553.
  • 7Matsubara J,Honda K,Ono M,et al.Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer.Cancer Epidemiol Biomarkers Prev,2011,20:160-171.
  • 8Pina F,Botelho F,Lopes T,et al.Can serum angiogenin be used to improve the diagnostic performance in prostate cancer screening? Eur J Cancer Prev,2013,in press.
  • 9Wang J,Wang X,Lin S,et al.Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.PloS One,2013,8:e70519.
  • 10Vincent M.Cancer:a de-repression of a default survival program common to all cells? A life-history perspective on the nature of cancer.Bioessays,2012,34:72-82.

共引文献5

同被引文献45

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部